The Sodium Bicarbonate Injection, cataloged under National Stock Number 6505-01-505-2377, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hospira Worldwide Llc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-505-2377 |
| Primary Part Number | NDC00409-6625-14 |
| Item Name | Sodium Bicarbonate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hospira Worldwide Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| American Hospital Formulary Service Classification Number | 400800 |
| Active Medicament Medicinal Strength | 84.000 MILLIGRAMS SODIUM BICARBONATE PER MILLILITER |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00409-6625-14 PRIMARY | Hospira Worldwide Llc (USA) |
| NDC00409-6625-35 PRIMARY | Hospira Worldwide Llc (USA) |
| NDC63323-0089-50 PRIMARY | Fresenius Kabi, Llc (USA) |
| Reference | Meaning |
|---|---|
| 03-0020 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-505-2377 is a Sodium Bicarbonate Injection, manufactured by Hospira Worldwide Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-505-2377 has 3 manufacturer part numbers on file: NDC00409-6625-14 (Hospira Worldwide Llc), NDC00409-6625-35 (Hospira Worldwide Llc), NDC63323-0089-50 (Fresenius Kabi, Llc).
Key specifications for NDC00409-6625-14: Primary Container Content Quantity: 50.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL; Special Features: PRESERVATIVE FREE; SINGLE DOSE VIAL. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.